4.5 Review

BST-2/tetherin: Structural biology, viral antagonism, and immunobiology of a potent host antiviral factor

Journal

MOLECULAR IMMUNOLOGY
Volume 54, Issue 2, Pages 132-139

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.molimm.2012.11.008

Keywords

Innate immunity; Tetherin; Virology; Interferon; Plasmacytoid dendritic cells; Antiviral state

Ask authors/readers for more resources

BST-2 (also known as tetherin, CD317, or HM1.24) was first described as a potent interferon-inducible host antiviral factor nearly five years ago. Since that time, numerous reports have been published regarding the antiviral activity and immunological properties of this protein. BST-2 blocks viral replication by inhibiting enveloped virus budding from the surface of infected cells. To counteract this, most viruses have developed strategies to antagonize BST-2, each employing a unique mechanism. In this review, we summarize the antiviral function, structural biology and immunobiology of BST-2. Taken together, our current understanding of BST-2 suggests potential avenues as well as challenges to exploiting its action in the development of broad spectrum antiviral treatments. (C) 2012 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

TREM-2 promotes macrophage survival and lung disease after respiratory viral infection

Kangyun Wu, Derek E. Byers, Xiaohua Jin, Eugene Agapov, Jennifer Alexander-Brett, Anand C. Patel, Marina Cella, Susan Gilfilan, Marco Colonna, Daniel L. Kober, Tom J. Brett, Michael J. Holtzman

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Article Biochemistry & Molecular Biology

First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes

Zeynep Yurtsever, Dhara A. Patel, Daniel L. Kober, Alvin Su, Chantel A. Miller, Arthur G. Romero, Michael J. Holtzman, Tom J. Brett

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)

Article Pharmacology & Pharmacy

Eact, a small molecule activator of TMEM16A, activates TRPV1 and elicits pain- and itch-related behaviours

Shenbin Liu, Jing Feng, Jialie Luo, Pu Yang, Thomas J. Brett, Hongzhen Hu

BRITISH JOURNAL OF PHARMACOLOGY (2016)

Article Multidisciplinary Sciences

Data publication with the structural biology data grid supports live analysis

Peter A. Meyer, Stephanie Socias, Jason Key, Elizabeth Ransey, Emily C. Tjon, Alejandro Buschiazzo, Ming Lei, Chris Botka, James Withrow, David Neau, Kanagalaghatta Rajashankar, Karen S. Anderson, Richard H. Baxter, Stephen C. Blacklow, Titus J. Boggon, Alexandre M. J. J. Bonvin, Dominika Borek, Tom J. Brett, Amedeo Caflisch, Chung-I Chang, Walter J. Chazin, Kevin D. Corbett, Michael S. Cosgrove, Sean Crosson, Sirano Dhe-Paganon, Enrico Di Cera, Catherine L. Drennan, Michael J. Eck, Brandt F. Eichman, Qing R. Fan, Adrian R. Ferre-D'Amare, J. Christopher Fromme, K. Christopher Garcia, Rachelle Gaudet, Peng Gong, Stephen C. Harrison, Ekaterina E. Heldwein, Zongchao Jia, Robert J. Keenan, Andrew C. Kruse, Marc Kvansakul, Jason S. McLellan, Yorgo Modis, Yunsun Nam, Zbyszek Otwinowski, Emil F. Pai, Pedro Jose Barbosa Pereira, Carlo Petosa, S. Raman, Tom A. Rapoport, Antonina Roll-Mecak, Michael K. Rosen, Gabby Rudenko, Joseph Schlessinger, Thomas U. Schwartz, Yousif Shamoo, Holger Sondermann, Yizhi J. Tao, Niraj H. Tolia, Oleg V. Tsodikov, Kenneth D. Westover, Hao Wu, Ian Foster, James S. Fraser, Filipe R. N. C. Maia, Tamir Gonen, Tom Kirchhausen, Kay Diederichs, Merce Crosas, Piotr Sliz

NATURE COMMUNICATIONS (2016)

Article Biology

Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms

Daniel L. Kober, Jennifer M. Alexander-Brett, Celeste M. Karch, Carlos Cruchaga, Marco Colonna, Michael J. Holtzman, Thomas J. Brett

ELIFE (2016)

Article Biochemistry & Molecular Biology

Modulation of TMEM16A channel activity by the von Willebrand factor type A (VWA) domain of the calcium-activated chloride channel regulator 1 (CLCA1)

Monica Sala-Rabanal, Zeynep Yurtsever, Kayla N. Berry, Colin G. Nichols, Tom J. Brett

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Review Biochemistry & Molecular Biology

TREM2-Ligand Interactions in Health and Disease

Daniel L. Kober, Tom J. Brett

JOURNAL OF MOLECULAR BIOLOGY (2017)

Review Biochemistry & Molecular Biology

Limiting Respiratory Viral Infection by Targeting Antiviral and Immunological Functions of BST-2/Tetherin: Knowledge and Gaps

Kayla N. Berry, Daniel L. Kober, Alvin Su, Tom J. Brett

BIOESSAYS (2018)

Article Biochemistry & Molecular Biology

The Ebola Viral Protein 35 N-Terminus Is a Parallel Tetramer

Chamnongsak Ken Chanthamontri, David S. Jordan, Wenjie Wang, Chao Wu, Yanchun Lin, Tom J. Brett, Michael L. Gross, Daisy W. Leung

BIOCHEMISTRY (2019)

Article Biochemistry & Molecular Biology

YbtT is a low-specificity type II thioesterase that maintains production of the metallophore yersiniabactin in pathogenic enterobacteria

Shannon I. Ohlemacher, Yiquan Xu, Daniel L. Kober, Mahnoor Malik, Jay C. Nix, Tom J. Brett, Jeffrey P. Henderson

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

Article Cell Biology

The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk

Yuetiva Deming, Fabia Filipello, Francesca Cignarella, Claudia Cantoni, Simon Hsu, Robert Mikesell, Zeran Li, Jorge L. Del-Aguila, Umber Dube, Fabiana Geraldo Farias, Joseph Bradley, John Budde, Laura Ibanez, Maria Victoria Fernandez, Kaj Blennow, Henrik Zetterberg, Amanda Heslegrave, Per M. Johansson, Johan Svensson, Bengt Nellgard, Alberto Lleo, Daniel Alcolea, Jordi Clarimon, Lorena Rami, Jose Luis Molinuevo, Marc Suarez-Calvet, Estrella Morenas-Rodriguez, Gernot Kleinberger, Michael Ewers, Oscar Harari, Christian Haass, Thomas J. Brett, Bruno A. Benitez, Celeste M. Karch, Laura Piccio, Carlos Cruchaga

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Clinical Neurology

Functional insights from biophysical study of TREM2 interactions with apoE and Aβ1-42

Daniel L. Kober, Melissa D. Stuchell-Brereton, Colin E. Kluender, Hunter B. Dean, Michael R. Strickland, Deborah F. Steinberg, Samantha S. Nelson, Berevan Baban, David M. Holtzman, Carl Frieden, Jennifer Alexander-Brett, Erik D. Roberson, Yuhua Song, Tom J. Brett

Summary: The study using comprehensive biolayer interferometry analysis revealed that TREM2 binds apoE through a protein-mediated mechanism, with slight affinity differences among isoforms; TREM2 and sTREM2 can directly bind mAβ42 and potently inhibit Aβ42 polymerization, suggesting a potential role in preventing AD pathogenesis.

ALZHEIMERS & DEMENTIA (2021)

Meeting Abstract Biophysics

Structural and functional investigations of CLCA proteins as potentiators of TMEM16 family members

Monica Sala-Rabanal, Kayla N. Berry, Colin G. Nichols, Thomas J. Brett

BIOPHYSICAL JOURNAL (2022)

Meeting Abstract Clinical Neurology

The MS4A Gene Cluster is a Key Modulator of Soluble TREM2 and Alzheimer Disease Risk

Fabia Filipello, Yuetiva Deming, Francesca Cignarella, Claudia Cantoni, Simon Hsu, Robert Mikesell, Zeran Li, Jorge Del-Aguila, Umber Dube, Fabiana Geraldo Farias, Joseph Bradley, John Budde, Laura Ibanez, Maria Victoria Fernandez, Kaj Blennow, Henrik Zetterberg, Amanda Heslegrave, Per M. Johansson, Johan Svensson, Bengt Nellgard, Alberto Lleo, Daniel Alcolea, Jordi Clarimon, Lorena Rami, Jose Luis Molinuevo, Marc Suarez-Calvet, Estrella Morenas-Rodriguez, Gernot Kleinberger, Michael Ewers, Oscar Harari, Christian Haass, Thomas J. Brett, Bruno A. Benitez, Celeste Karch, Laura Piccio, Carlos Cruchaga

ANNALS OF NEUROLOGY (2019)

No Data Available